CG
RVNC

Cutler Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Cutler Group’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,760
Closed -$87K – 4893
2022
Q4 		$87K Buy
+4,760
New +$109K 0.01% 1246
2022
Q2 		– Sell
-8,530
Closed -$131K – 5840
2022
Q1 		$166K Buy
8,530
+7,604
+821% +$115K 0.01% 1328
2021
Q4 		$15K Buy
+926
New +$15.4K ﹤0.01% 3380
2020
Q1 		– Sell
-1,300
Closed -$21K – 4801
2019
Q4 		$21K Sell
1,300
-100
-7% -$1.55K ﹤0.01% 2194
2019
Q3 		$18K Hold
1,400
– – ﹤0.01% 2272
2019
Q2 		$18K Hold
1,400
– – ﹤0.01% 2302
2019
Q1 		$22K Hold
1,400
– – ﹤0.01% 2000
2018
Q4 		$28K Sell
1,400
-500
-26% -$11K ﹤0.01% 1880
2018
Q3 		$47K Buy
1,900
+200
+12% +$5.44K ﹤0.01% 1655
2018
Q2 		$46K Buy
1,700
+600
+55% +$18K ﹤0.01% 1660
2018
Q1 		$33K Sell
1,100
-1,500
-58% -$48.3K ﹤0.01% 1950
2017
Q4 		$92K Buy
2,600
+2,000
+333% +$57.4K ﹤0.01% 1431
2017
Q3 		$16K Sell
600
-1,616
-73% -$39.2K ﹤0.01% 3366
2017
Q2 		$58K Sell
2,216
-5,074
-70% -$113K ﹤0.01% 2351
2017
Q1 		$151K Sell
7,290
-800
-10% -$16.4K 0.01% 1400
2016
Q4 		$167K Sell
8,090
-4,400
-35% -$73.7K 0.01% 1446
2016
Q3 		$202K Buy
12,490
+6,144
+97% +$89.2K 0.01% 1202
2016
Q2 		$86K Sell
6,346
-1,208
-16% -$21.4K ﹤0.01% 1830
2016
Q1 		$131K Buy
7,554
+800
+12% +$16.3K 0.01% 1360
2015
Q4 		$230K Buy
+6,754
New +$234K 0.01% 1076

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cutler Group's RVNC Position: Q1 2023 in Review

Cutler Group sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2023, closing a stake of 4,760 shares — an estimated $87K sold.

Cutler Group first reported a position in RVNC in Q4 2015 and held it in 20 quarters. The position peaked at $230K in Q4 2015. 216 funds tracked by Wall St. Rank hold RVNC as of Q1 2023.

  • Cutler Group reported no remaining Revance Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 4,760 Revance Therapeutics, Inc. shares in Q1 2023, an estimated $87K.
  • Cutler Group first reported a position in Revance Therapeutics, Inc. in Q4 2015 and held it in 20 quarters.
  • Cutler Group's Revance Therapeutics, Inc. position peaked at $230K in Q4 2015.
  • 216 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.